Unlike conventional genome editing tools that often rely on the CRISPR-Cas9 nuclease to generate double-strand breaks, the TKO system capitalizes on the refined mechanisms of prime editing, specifically augmenting it with a twin prime editing strategy. Central to this approach is the installation of stop codon clusters (SCCs) within target genes, a strategy that ensures precise and irreversible translational termination. This innovation drastically mitigates the risk of generating in-frame mutations that can undermine knockout efficacy—a chronic challenge in conventional editing paradigms.

Empirical results underscore the potency of TKO, demonstrating knockout efficiencies that soar as high as 70.5% in rice, 58.6% in maize, and 75.1% in wheat protoplasts. Such levels of efficacy represent a substantial improvement over prior editing systems, which faced obstacles in achieving high-frequency, precise edits without off-target disruptions or partial gene activity retention. Moreover, the heritability of these knockout alleles is striking, with a reported 96.8% transmission rate in regenerated rice plants, which speaks to the system’s robustness and practicality for crop breeding programs.

Perhaps most compelling is the performance of TKO in hexaploid wheat, a particularly challenging genetic background due to its complex genome. Here, the TKO system surpasses Cas9 efficiency by a factor of 4.2 in generating triple-homolog knockouts. This achievement largely stems from TKO’s reduced propensity for inducing in-frame mutations, which often compromise gene knockout functionality in polyploid species. This breakthrough could accelerate wheat breeding efforts that rely on simultaneous disruption of multiple gene copies, a heretofore daunting task.

The versatility of the system is further enhanced by the development of orthogonal TKO editors, each employing sequence-divergent SCCs. This orthogonality enables the simultaneous knockout of up to ten different genes within a single experimental framework without cross-interference—a feat unparalleled by existing multiplex editing platforms. The potential implications for complex trait engineering are profound, offering avenues to decode polygenic traits and engineer multi-gene networks with unprecedented control.

Integration of the TKO approach with conventional prime editing techniques culminates in the construction of the TRIM1 system (TKO editor-enabled gene rupture and development of integrated multitype genome modification system). This hybrid platform facilitates concurrent knockout and precise editing across multiple genes, achieving coediting frequencies of 22.8% for four targeted genes in rice. Such multiplexed editing strategies portend a new era where breeding objectives like yield enhancement, disease resistance, and stress tolerance can be achieved simultaneously through precise genetic interventions.

Expanding the capabilities of TRIM1, the TRIM2 system pushes the frontier by harmonizing prime editing with a recombinase-based strategy, enabling modifications at a kilobase scale. This is exemplified by a 4.9-kilobase insertion achieved at a 1.2% efficiency alongside knockout frequencies approaching 80% in protoplast contexts. These developments underscore the feasibility of not only gene disruption but also large-scale genomic insertions within monocot genomes, broadening the spectrum of achievable genetic architectures for crop improvement.

The TKO and TRIM systems collectively enrich the toolkit available for functional genomics and breeding in monocots, species that underpin global food security. By meticulously installing SCCs, they enforce translational termination without indel-induced frameshifts, a nuance that substantially reduces unintended gene products and off-target effects. This technical sophistication heralds a paradigm shift, potentially enabling precision trait engineering at a scale and fidelity previously unattainable.

Underlying these advancements is a rigorous validation across multiple species and genomic contexts. The fact that TKO excels in hexaploid wheat—a genome historically resistant to efficient editing—attests to its broad applicability and robustness. The capacity for stable transmission of edits further ensures that traits engineered using this platform will sustain through successive generations, a critical requirement for agricultural deployment.

Beyond the laboratory, the scalability of TKO and its orthogonal variants portends transformative impacts on breeding timelines and outcomes. Traditional breeding for complex traits often involves protracted cycles of selection and crossing, complicated by genomic redundancy and gene network interactions. TKO’s multiplexed precision editing offers a shortcut, directly creating desirable genotype combinations in a single generation, which could accelerate the commercialization of improved crop varieties.

Moreover, the modularity of the TKO design enables researchers to tailor editing strategies to specific genomic architectures and trait frameworks. By selecting divergent SCC sequences and prime editing configurations, off-target risks are minimized and editing efficiency optimized. This bespoke engineering approach aligns with the broader goals of sustainable agriculture, where genetic interventions must be precise, efficient, and context-specific to minimize unintended ecological and agronomic risks.

As genome engineering technologies advance, ethical and regulatory considerations remain paramount. The non-nuclease-based editing inherent to prime and twin prime editing methodologies may offer advantages in terms of regulatory acceptance and public perception, given the reduced reliance on double-strand breaks and potential off-target mutagenesis. The precise gene termination approach of TKO could bolster arguments for these technologies’ safety and predictability, conducive to broader adoption.

Looking forward, the integration of TKO with other molecular breeding tools, high-throughput phenotyping, and genomic selection platforms could catalyze a new era of functional crop genomics. Such integrative approaches could unlock complex trait architectures that have so far eluded traditional strategies, fostering resilient, high-yielding, and climate-adaptive crop cultivars vital for future food security.

In conclusion, the twin prime editing-based knockout system represents a seminal contribution to plant genome engineering. By enabling efficient, multiplexed, and precise gene knockouts with minimal in-frame mutations and facilitating concomitant large-scale genome edits, this platform lays the foundation for accelerated and sophisticated crop improvement. Its implementation across key monocot species heralds a leap forward in agricultural biotechnology, promising to reshape how genomic tools are deployed to sustain and enhance global food systems.

Subject of Research: Genome engineering in monocot crops using twin prime editing systems for multiplexed, precise gene knockouts and large-scale genomic insertions.

Article Title: Multiplexed, precise genome engineering in monocots with twin prime editing systems.

Article References:
Li, H., Chai, Z., Shi, X. et al. Multiplexed, precise genome engineering in monocots with twin prime editing systems. Nat Biotechnol (2026). https://doi.org/10.1038/s41587-026-03174-5

DOI: https://doi.org/10.1038/s41587-026-03174-5

Prime editing, known for its ability to introduce targeted insertions, deletions, or base conversions within the genome, is typically restricted to short DNA segments. Similarly, Gibson assembly is a laboratory method that allows the seamless joining of multiple DNA fragments in a controlled, single-reaction setting. By ingeniously combining these methods, prime assembly expands the horizon of genomic editing to unprecedented lengths, potentially analogous to swapping an entire paragraph or chapter in a vast genetic manuscript rather than just a single letter or word.

Erik Sontheimer, PhD, Pillar Chair in Biomedical Research and a professor specializing in RNA therapeutics, explains that existing gene editing technologies—including prime editing, base editing, and CRISPR-Cas9—are largely limited to swapping out small snippets of genetic code, comparable to editing individual characters in text. The novel prime assembly system circumvents these constraints, furnishing the capability to insert gene-length sequences efficiently and accurately, thereby addressing genetic disorders associated with large mutations or clusters of mutations dispersed across genes.

Published in the prestigious journal Nature, this research embodies a collaborative effort involving notable experts such as Wen Xue, PhD, Professor of RNA Therapeutics, Scot A. Wolfe, PhD, and several dedicated students and postdoctoral fellows from the UMass Chan community. Their collective insights and technological advancements represent a significant leap forward in precisely correcting vast genomic defects with potential clinical applications in gene therapy.

One of the primary challenges in treating genetic diseases stems from the myriad mutations present within individual genes, necessitating multiple, mutation-specific therapeutic interventions. Current technologies falter when faced with this complexity, as they excel only at small edits and require tailored approaches for each mutation, which is neither efficient nor practical. Prime assembly resolves this by enabling scientists to insert DNA insertions as long as 11,000 base pairs, encompassing entire gene sequences and thereby simplifying therapeutic design.

Technically, prime assembly employs a twin prime editing approach to generate programmable single-stranded DNA flaps at the target genomic locus. These flaps precisely anneal to complementary regions on the donor DNA, facilitating seamless integration without creating double-strand breaks (DSBs), which are prone to causing unpredictable mutations or deletions due to error-prone cellular repair mechanisms. Instead, prime assembly induces single-strand nicks, a gentler approach that minimizes deleterious consequences on genome integrity and cellular viability.

The elegance of this technology lies not only in the scale of DNA it can incorporate but also in the streamlined nature of its process compared to other large-sequence insertion methods. Traditional gene editing techniques that enable sizable insertions often involve complex viral delivery systems or induce more damaging genomic interventions. Prime assembly’s methodology bypasses these pitfalls, making it a biotechnological breakthrough with promising implications for both research and eventual clinical translation.

Another remarkable advantage of prime assembly is its effectiveness in nondividing cells, such as neurons. Many current gene editing modalities are optimized for dividing cells, limiting their utility in treating neurological disorders or other conditions involving quiescent cells. By operating efficiently within cells that do not frequently divide, prime assembly opens avenues for addressing a broader array of diseases previously deemed inaccessible to gene replacement therapies.

Moreover, prime assembly’s intrinsic capacity to join multiple DNA fragments mirrors the functionality of Gibson assembly in vitro but accomplishes it within the genomic context. This ability to stitch together several DNA strands endogenously broadens possibilities for creating more complex genetic modifications, including the insertion of synthetic genes, regulatory sequences, or entire genomic loci, which could revolutionize synthetic biology and therapeutic gene design.

Looking ahead, the research team aims to unravel the precise endogenous cellular mechanisms that prime assembly engages to mediate DNA joining within the genome. A deeper understanding of these native processes may illuminate how to further enhance the efficiency and safety of prime assembly, while also guiding its adaptation to diverse cell types and organisms. Parallelly, preclinical studies in animal models are poised to evaluate the therapeutic potentials and biosafety of this technology, fostering progress toward clinical applications.

The development of prime assembly represents a critical advance toward the overarching goal of gene therapy: to create versatile, efficient, and broadly applicable tools capable of repairing the vast spectrum of genetic mutations that underlie human disease. By enabling the insertion of large DNA sequences with precision and minimal genomic disruption, prime assembly stands to transform the landscape of genetic medicine, offering hope for patients with complex genetic disorders.

UMass Chan Medical School, home to this breakthrough research, is a hub of innovation, integrating cutting-edge biomedical science with translational initiatives aimed at addressing global health challenges. Their interdisciplinary approach combines expertise in RNA therapeutics, molecular biology, and genetic engineering, nurturing an environment where transformative technologies like prime assembly can emerge and thrive.

As the field of genome engineering continues to expand rapidly, prime assembly sets a new benchmark for what is achievable in editing the human genome. Its convergence of prime editing’s precision and Gibson assembly’s assembly prowess encapsulates the future of gene therapy: precise, scalable, and capable of tackling genetic diseases at an unprecedented scale and complexity.

The implications of this technology extend beyond gene therapy alone, impacting research areas such as functional genomics, synthetic biology, and regenerative medicine. With its ability to rewrite extensive sections of the genome, prime assembly empowers researchers to probe genetic functions in greater detail and devise innovative strategies to counteract disease.

In conclusion, the advent of prime assembly redefines the frontier of genomic editing, heralding a new era where entire genes, not just snippets, can be seamlessly edited, inserted, and replaced. This landmark innovation aligns with the vision of personalized medicine, promising tailored, effective treatments for patients burdened by the complexity of genetic disease.

Subject of Research: Cells

Article Title: Prime assembly with linear DNA donors enables large genomic insertions

News Publication Date: April 29, 2026

Web References:
https://www.nature.com/articles/s41586-026-10460-4

References:
Sontheimer, E., Xue, W., et al. (2026). Prime assembly with linear DNA donors enables large genomic insertions. Nature. DOI: 10.1038/s41586-026-10460-4.

Image Credits: Bryan Goodchild, UMass Chan Medical School

Keywords: Gene editing, Gene therapy, Genetics, Genetic engineering, Gene delivery, Genomics, Human genetics, Molecular genetics, Molecular biology, Nucleic acids